Oxford Asset Management’s Guardant Health GH Stock Holding History

Oxford Asset Management’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$251K	Buy	+2,720	New	+$273K	0.11%	289
2025 Q4	–	Sell	-12,358	Closed	-$772K	–	586
2025 Q3	$772K	Buy	+12,358	New	+$672K	0.26%	112
2024 Q3	–	Sell	-8,648	Closed	-$250K	–	364
2024 Q2	$250K	Sell	8,648 -7,352	-46%	-$171K	0.24%	169
2024 Q1	$330K	Buy	+16,000	New	+$343K	0.34%	97
2019 Q1	–	Sell	-52,473	Closed	-$1.97M	–	1773
2018 Q4	$1.97M	Buy	+52,473	New	+$1.93M	0.05%	473

Other funds holding GH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Oxford Asset Management's GH Position: Q1 2026 in Review

Oxford Asset Management opened a new position in Guardant Health (GH) in Q1 2026: 2,720 shares worth $251K. The stake represents 0.11% of the portfolio and ranks #289 among its holdings. This is a return to the name: Oxford Asset Management previously reported a position in GH as recently as Q3 2025.

Oxford Asset Management first reported a position in GH in Q4 2018 and has held it in 5 quarters since. The position peaked at $1.97M in Q4 2018. 481 funds tracked by Wall St. Rank hold GH as of Q1 2026.

Oxford Asset Management held 2,720 shares of Guardant Health worth $251K as of Q1 2026.
Guardant Health was a new Oxford Asset Management position in Q1 2026.
Guardant Health made up 0.11% of Oxford Asset Management's portfolio in Q1 2026, its #289 holding.
Oxford Asset Management first reported a position in Guardant Health in Q4 2018 and has held it in 5 quarters since.
Oxford Asset Management's Guardant Health position peaked at $1.97M in Q4 2018.
481 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on Oxford Asset Management's 13F filing for Q1 2026, filed 15 May 2026.